Nasal high flow in patients with exacerbation COPD and/or pneumonia on the lungward

Nasal high flow in patients with exacerbation COPD and/or pneumonia on the lungward - Nasal high flow in patients witch COPD and/of pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON54519

Enrollment

210

Registered

2019-11-04

Start date

2019-12-03

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD pneumonia

Interventions

Nasal high flow oxygen therapy

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: exacerbation COPD and/or pneumonia admitted on the lung ward using oxygen, no less than 1 litre/minute

Exclusion criteria

Exclusion criteria: acute hypercapnia or acidosis, pneumothorax delirium domestic use of Bi-pap or C-pap

Design outcomes

Primary

Measure	Time frame
Primaire parameter is comfort. we ask patients to complete CCQ daily during admittion.	—

Secondary

Measure	Time frame
Besides the primaire parameter, there will also measurements to investigate cough, dyspnea, oxygenation, respiration, heartfrequency, viscocity of the mucus and duration of admittion	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)